Veracyte Statistics
Share Statistics
Veracyte has 77.50M shares outstanding. The number of shares has increased by 3.24% in one year.
| Shares Outstanding | 77.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.9% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 76.55M |
| Failed to Deliver (FTD) Shares | 89 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 2.55M, so 3.29% of the outstanding shares have been sold short.
| Short Interest | 2.55M |
| Short % of Shares Out | 3.29% |
| Short % of Float | 3.34% |
| Short Ratio (days to cover) | 3.1 |
Valuation Ratios
The PE ratio is -26.86 and the forward PE ratio is 97.54.
| PE Ratio | -26.86 |
| Forward PE | 97.54 |
| PS Ratio | 5.54 |
| Forward PS | null |
| PB Ratio | 1.91 |
| P/FCF Ratio | 58.33 |
| PEG Ratio | n/a |
Enterprise Valuation
Veracyte Inc. has an Enterprise Value (EV) of 1.79B.
| EV / Earnings | -24.12 |
| EV / Sales | 4.97 |
| EV / EBITDA | -36.32 |
| EV / EBIT | -20.92 |
| EV / FCF | 52.38 |
Financial Position
The company has a current ratio of 4.66, with a Debt / Equity ratio of 0.
| Current Ratio | 4.66 |
| Quick Ratio | 4.4 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -5719.67 |
Financial Efficiency
Return on equity (ROE) is -0.07% and return on capital (ROIC) is -7.88%.
| Return on Equity (ROE) | -0.07% |
| Return on Assets (ROA) | -0.07% |
| Return on Capital (ROIC) | -7.88% |
| Revenue Per Employee | 443.01K |
| Profits Per Employee | -91.29K |
| Employee Count | 815 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 7 |
Taxes
| Income Tax | -2.21M |
| Effective Tax Rate | 0.03 |
Stock Price Statistics
The stock price has increased by 53.94% in the last 52 weeks. The beta is 1.67, so Veracyte 's price volatility has been higher than the market average.
| Beta | 1.67 |
| 52-Week Price Change | 53.94% |
| 50-Day Moving Average | 40.47 |
| 200-Day Moving Average | 29.54 |
| Relative Strength Index (RSI) | 48.85 |
| Average Volume (20 Days) | 760.28K |
Income Statement
In the last 12 months, Veracyte had revenue of 361.05M and earned -74.40M in profits. Earnings per share was -1.02.
| Revenue | 361.05M |
| Gross Profit | 248.15M |
| Operating Income | -85.80M |
| Net Income | -74.40M |
| EBITDA | -49.41M |
| EBIT | -85.80M |
| Earnings Per Share (EPS) | -1.02 |
Balance Sheet
The company has 216.45M in cash and 12.63M in debt, giving a net cash position of 203.82M.
| Cash & Cash Equivalents | 216.45M |
| Total Debt | 12.63M |
| Net Cash | 203.82M |
| Retained Earnings | -468.12M |
| Total Assets | 1.28B |
| Working Capital | 286.54M |
Cash Flow
In the last 12 months, operating cash flow was 44.22M and capital expenditures -9.96M, giving a free cash flow of 34.26M.
| Operating Cash Flow | 44.22M |
| Capital Expenditures | -9.96M |
| Free Cash Flow | 34.26M |
| FCF Per Share | 0.47 |
Margins
Gross margin is 68.73%, with operating and profit margins of -23.76% and -20.61%.
| Gross Margin | 68.73% |
| Operating Margin | -23.76% |
| Pretax Margin | -21.22% |
| Profit Margin | -20.61% |
| EBITDA Margin | -13.68% |
| EBIT Margin | -23.76% |
| FCF Margin | 9.49% |
Dividends & Yields
VCYT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2.49% |
| FCF Yield | 1.08% |
Analyst Forecast
The average price target for VCYT is $42, which is 2.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $42 |
| Price Target Difference | 2.5% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Scores
| Altman Z-Score | 20.48 |
| Piotroski F-Score | 4 |